Telix Pharmaceuticals TLX
NASDAQ TLX
$9.63 +0.21 (+2.23%)
At close: Nov 6, 2026 · 4:00 PM EST

Telix Pharmaceuticals (TLX) Short-term Investments (2023 - 2026)

Updated

Telix Pharmaceuticals' Short-term Investments was $40.41 million in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Short-term Investments (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Short-term Investments at Telix Pharmaceuticals came in at $37.09 million, up 6.8% from the prior year.

  • In earlier years, Short-term Investments was $34.75 million in the year ended Dec 31, 2024 (+314.3%) and $8.39 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Telix Pharmaceuticals 3.26 Bn 2.22 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.41 Mn
Dec 31, 2025 37.09 Mn
Dec 31, 2024 34.89 Mn
Dec 31, 2023 8.37 Mn
API Access

Telix Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=TLX&period=max&api_key=YOUR_API_KEY